HealthTech company focused on early detection of breast cancer, Volpara Health (ASX: VHT), has reported a fourth consecutive positive net…
Over 20,000 Aussies are diagnosed with breast cancer every year and is the most commonly diagnosed cancer among women in…
Precision diagnostics company INOVIQ (ASX: IIQ) has achieved noteworthy results from an independent clinical validation study of its SubB2M/CA15-3 test…
In 2018, breast cancer was the most commonly diagnosed cancer in Australia. A position it held until 2022. What’s more?…
With 1 in 7 Australian women diagnosed with breast cancer, the demand for a minimally invasive, accurate diagnostic test is…
At a time when women are more aware of potential health issues than ever, Volpara Health (ASX: VHT) is set…